Cargando…

Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids

BACKGROUND: Resistance to oxaliplatin is a major obstacle for the management of locally advanced and metastatic colon cancer (CC). Although long noncoding RNAs (lncRNAs) play key roles in CC, the relationships between lncRNAs and resistance to oxaliplatin have been poorly understood yet. METHODS: Ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qingguo, Sun, Huizhen, Luo, Dakui, Gan, Lu, Mo, Shaobo, Dai, Weixing, Liang, Lei, Yang, Yufei, Xu, Midie, Li, Jing, Zheng, Peiyong, Li, Xinxiang, Li, Yan, Wang, Ziliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570024/
https://www.ncbi.nlm.nih.gov/pubmed/34740372
http://dx.doi.org/10.1186/s13046-021-02143-x
_version_ 1784594759675805696
author Li, Qingguo
Sun, Huizhen
Luo, Dakui
Gan, Lu
Mo, Shaobo
Dai, Weixing
Liang, Lei
Yang, Yufei
Xu, Midie
Li, Jing
Zheng, Peiyong
Li, Xinxiang
Li, Yan
Wang, Ziliang
author_facet Li, Qingguo
Sun, Huizhen
Luo, Dakui
Gan, Lu
Mo, Shaobo
Dai, Weixing
Liang, Lei
Yang, Yufei
Xu, Midie
Li, Jing
Zheng, Peiyong
Li, Xinxiang
Li, Yan
Wang, Ziliang
author_sort Li, Qingguo
collection PubMed
description BACKGROUND: Resistance to oxaliplatin is a major obstacle for the management of locally advanced and metastatic colon cancer (CC). Although long noncoding RNAs (lncRNAs) play key roles in CC, the relationships between lncRNAs and resistance to oxaliplatin have been poorly understood yet. METHODS: Chemo-sensitive and chemo-resistant organoids were established from colon cancer tissues of the oxaliplatin-sensitive or -resistant patients. Analysis of the patient cohort indicated that lnc-RP11-536 K7.3 had a potential oncogenic role in CC. Further, a series of functional in vitro and in vivo experiments were conducted to assess the effects of lnc-RP11-536 K7.3 on CC proliferation, glycolysis, and angiogenesis. RNA pull-down assay, luciferase reporter and fluorescent in situ hybridization assays were used to confirm the interactions between lnc-RP11-536 K7.3, SOX2 and their downstream target HIF-1α. RESULTS: In this study, we identified a novel lncRNA, lnc-RP11-536 K7.3, was associated with resistance to oxaliplatin and predicted a poor survival. Knockout of lnc-RP11-536 K7.3 inhibited the proliferation, glycolysis, and angiogenesis, whereas enhanced chemosensitivity in chemo-resistant organoids and CC cells both in vitro and in vivo. Furthermore, we found that lnc-RP11-536 K7.3 recruited SOX2 to transcriptionally activate USP7 mRNA expression. The accumulative USP7 resulted in deubiquitylation and stabilization of HIF-1α, thereby facilitating resistance to oxaliplatin. CONCLUSION: In conclusion, our findings indicated that lnc-RP11-536 K7.3 could promote proliferation, glycolysis, angiogenesis, and chemo-resistance in CC by SOX2/USP7/HIF-1α signaling axis. This revealed a new insight into how lncRNA could regulate chemosensitivity and provide a potential therapeutic target for reversing resistance to oxaliplatin in the management of CC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-021-02143-x.
format Online
Article
Text
id pubmed-8570024
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85700242021-11-08 Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids Li, Qingguo Sun, Huizhen Luo, Dakui Gan, Lu Mo, Shaobo Dai, Weixing Liang, Lei Yang, Yufei Xu, Midie Li, Jing Zheng, Peiyong Li, Xinxiang Li, Yan Wang, Ziliang J Exp Clin Cancer Res Research BACKGROUND: Resistance to oxaliplatin is a major obstacle for the management of locally advanced and metastatic colon cancer (CC). Although long noncoding RNAs (lncRNAs) play key roles in CC, the relationships between lncRNAs and resistance to oxaliplatin have been poorly understood yet. METHODS: Chemo-sensitive and chemo-resistant organoids were established from colon cancer tissues of the oxaliplatin-sensitive or -resistant patients. Analysis of the patient cohort indicated that lnc-RP11-536 K7.3 had a potential oncogenic role in CC. Further, a series of functional in vitro and in vivo experiments were conducted to assess the effects of lnc-RP11-536 K7.3 on CC proliferation, glycolysis, and angiogenesis. RNA pull-down assay, luciferase reporter and fluorescent in situ hybridization assays were used to confirm the interactions between lnc-RP11-536 K7.3, SOX2 and their downstream target HIF-1α. RESULTS: In this study, we identified a novel lncRNA, lnc-RP11-536 K7.3, was associated with resistance to oxaliplatin and predicted a poor survival. Knockout of lnc-RP11-536 K7.3 inhibited the proliferation, glycolysis, and angiogenesis, whereas enhanced chemosensitivity in chemo-resistant organoids and CC cells both in vitro and in vivo. Furthermore, we found that lnc-RP11-536 K7.3 recruited SOX2 to transcriptionally activate USP7 mRNA expression. The accumulative USP7 resulted in deubiquitylation and stabilization of HIF-1α, thereby facilitating resistance to oxaliplatin. CONCLUSION: In conclusion, our findings indicated that lnc-RP11-536 K7.3 could promote proliferation, glycolysis, angiogenesis, and chemo-resistance in CC by SOX2/USP7/HIF-1α signaling axis. This revealed a new insight into how lncRNA could regulate chemosensitivity and provide a potential therapeutic target for reversing resistance to oxaliplatin in the management of CC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-021-02143-x. BioMed Central 2021-11-05 /pmc/articles/PMC8570024/ /pubmed/34740372 http://dx.doi.org/10.1186/s13046-021-02143-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Li, Qingguo
Sun, Huizhen
Luo, Dakui
Gan, Lu
Mo, Shaobo
Dai, Weixing
Liang, Lei
Yang, Yufei
Xu, Midie
Li, Jing
Zheng, Peiyong
Li, Xinxiang
Li, Yan
Wang, Ziliang
Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids
title Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids
title_full Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids
title_fullStr Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids
title_full_unstemmed Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids
title_short Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids
title_sort lnc-rp11-536 k7.3/sox2/hif-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570024/
https://www.ncbi.nlm.nih.gov/pubmed/34740372
http://dx.doi.org/10.1186/s13046-021-02143-x
work_keys_str_mv AT liqingguo lncrp11536k73sox2hif1asignalingaxisregulatesoxaliplatinresistanceinpatientderivedcolorectalcancerorganoids
AT sunhuizhen lncrp11536k73sox2hif1asignalingaxisregulatesoxaliplatinresistanceinpatientderivedcolorectalcancerorganoids
AT luodakui lncrp11536k73sox2hif1asignalingaxisregulatesoxaliplatinresistanceinpatientderivedcolorectalcancerorganoids
AT ganlu lncrp11536k73sox2hif1asignalingaxisregulatesoxaliplatinresistanceinpatientderivedcolorectalcancerorganoids
AT moshaobo lncrp11536k73sox2hif1asignalingaxisregulatesoxaliplatinresistanceinpatientderivedcolorectalcancerorganoids
AT daiweixing lncrp11536k73sox2hif1asignalingaxisregulatesoxaliplatinresistanceinpatientderivedcolorectalcancerorganoids
AT lianglei lncrp11536k73sox2hif1asignalingaxisregulatesoxaliplatinresistanceinpatientderivedcolorectalcancerorganoids
AT yangyufei lncrp11536k73sox2hif1asignalingaxisregulatesoxaliplatinresistanceinpatientderivedcolorectalcancerorganoids
AT xumidie lncrp11536k73sox2hif1asignalingaxisregulatesoxaliplatinresistanceinpatientderivedcolorectalcancerorganoids
AT lijing lncrp11536k73sox2hif1asignalingaxisregulatesoxaliplatinresistanceinpatientderivedcolorectalcancerorganoids
AT zhengpeiyong lncrp11536k73sox2hif1asignalingaxisregulatesoxaliplatinresistanceinpatientderivedcolorectalcancerorganoids
AT lixinxiang lncrp11536k73sox2hif1asignalingaxisregulatesoxaliplatinresistanceinpatientderivedcolorectalcancerorganoids
AT liyan lncrp11536k73sox2hif1asignalingaxisregulatesoxaliplatinresistanceinpatientderivedcolorectalcancerorganoids
AT wangziliang lncrp11536k73sox2hif1asignalingaxisregulatesoxaliplatinresistanceinpatientderivedcolorectalcancerorganoids